• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[广西血清抗P53与肝细胞癌家族聚集性的相关性]

[Correlation between serum anti-P53 and familial clustering of hepatocellular carcinoma in Guangxi].

作者信息

Pang Yu, Li Guo-jian, Wu Ji-zhou, Wu Jian-lin, Chen Wu-qing, Ning Qiu-yue, Wei Ying-hua, Hu Die-fei, Qin Ling

机构信息

Department of Infectious Diseases, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.

出版信息

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Apr;29(2):206-9. doi: 10.3760/cma.j.issn.1003-9406.2012.02.019.

DOI:10.3760/cma.j.issn.1003-9406.2012.02.019
PMID:22487835
Abstract

OBJECTIVE

To assess the correlation between familial clustering of hepatocellular carcinoma (HCC) and the level of anti-P53 in human serum in Guangxi.

METHODS

Enzyme-linked immunosorbent assay (ELISA) was used to detect anti-P53 in 164 members from 20 HCC families and 164 members from non-cancer control families. Univariate analysis was performed to assess the correlation between seral level of P53 antibody and familial clustering of HCC.

RESULTS

The level of P53 antibody was significantly higher in the members of HCC families than controls (Z=-3.04, P=0.002). After eliminating the interference of hepatitis B virus infection, this tendency still remains (P=0.011). And there was a significant difference between relatives of different degrees from HCC families (chi-square=11.593, P=0.021), with the expression of anti-P53 declining along with decrease in relationship coefficient. Furthermore, the number of individuals with high anti-P53 expression was also significantly greater in HCC families (95/164) than controls (71/164) (P=0.006). And the expression was rising along with the increasing HCC numbers (chi-square=16.068, P=0.000). Anti-P53 level was also greater in HCC families featuring sibling affection than parental affection (chi-square=12.679, P=0.002). Univariate analysis indicated that high expression of anti-P53 is a risk factor for development of HCC (OR=2.087, 95%CI: 1.270-3.431).

CONCLUSION

High level of anti-P53 expression may be a factor for the clustering of HCC families in Guangxi, China.

摘要

目的

评估广西地区肝细胞癌(HCC)家族聚集性与人体血清中抗P53水平之间的相关性。

方法

采用酶联免疫吸附测定(ELISA)法检测20个HCC家族的164名成员及非癌对照家族的164名成员血清中的抗P53。进行单因素分析以评估P53抗体血清水平与HCC家族聚集性之间的相关性。

结果

HCC家族成员的P53抗体水平显著高于对照组(Z = -3.04,P = 0.002)。排除乙型肝炎病毒感染的干扰后,这种趋势仍然存在(P = 0.011)。HCC家族不同程度亲属之间存在显著差异(χ² = 11.593,P = 0.021),抗P53的表达随亲缘系数降低而下降。此外,抗P53高表达个体的数量在HCC家族(95/164)中也显著多于对照组(71/164)(P = 0.006)。并且其表达随HCC病例数增加而上升(χ² = 16.068,P = 0.000)。在以兄弟姐妹关系为主的HCC家族中抗P53水平也高于以父母子女关系为主的家族(χ² = 12.679,P = 0.002)。单因素分析表明抗P53高表达是HCC发生的危险因素(OR = 2.087,95%CI:1.270 - 3.431)。

结论

抗P53高表达可能是中国广西地区HCC家族聚集的一个因素。

相似文献

1
[Correlation between serum anti-P53 and familial clustering of hepatocellular carcinoma in Guangxi].[广西血清抗P53与肝细胞癌家族聚集性的相关性]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Apr;29(2):206-9. doi: 10.3760/cma.j.issn.1003-9406.2012.02.019.
2
Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.欧洲肝细胞癌患者循环抗 p53 抗体的临床意义
Br J Cancer. 1999 Feb;79(3-4):604-10. doi: 10.1038/sj.bjc.6690095.
3
[Prevalence and prognostic value of serum anti-p53 antibodies in hepatocellular carcinoma. A study of 159 patients].[肝细胞癌患者血清抗p53抗体的患病率及预后价值。对159例患者的研究]
Gastroenterol Clin Biol. 2000 Dec;24(12):1159-63.
4
[Study on the relationship between familial clustering of hepatocellular carcinoma and polymorphism of cytochrome P450 2E1 gene in Zhuang population, Guangxi].广西壮族人群肝细胞癌家族聚集性与细胞色素P450 2E1基因多态性的关系研究
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Feb;30(2):151-5.
5
Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.慢性丙型肝炎病毒感染相关的肝纤维化、肝硬化或肝细胞癌患者肝脏及血清中p53蛋白的表达
Clin Biochem. 2009 Apr;42(6):455-61. doi: 10.1016/j.clinbiochem.2008.11.004. Epub 2008 Nov 27.
6
Evaluation of the pattern and prognostic implications of anti-p53 in hepatocellular carcinoma.肝细胞癌中抗p53的模式及预后意义评估
Singapore Med J. 2007 Jan;48(1):41-4.
7
Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.三种肝炎标志物(p53抗体、血管内皮生长因子和甲胎蛋白)在肝细胞癌患者中的预后意义。
Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1417-24.
8
Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China.在中国西北地区,具有不良预后的家族性聚集感染中乙型肝炎病毒感染。
J Med Virol. 2013 Nov;85(11):1893-9. doi: 10.1002/jmv.23649. Epub 2013 Aug 9.
9
Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma.血清抗p53抗体作为埃及肝细胞癌患者预后因素的价值。
Clin Biochem. 2008 Oct;41(14-15):1131-9. doi: 10.1016/j.clinbiochem.2008.06.006. Epub 2008 Jun 20.
10
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status.肝细胞癌患者对p53的体液免疫反应具有肿瘤特异性,且与甲胎蛋白状态无关。
Hepatology. 1993 Sep;18(3):559-65.